|
Upcoming Events
| Details on upcoming events are not yet available. Please click here to be notified of all upcoming events. |
Archived Events
|
|
The abstract "Phase 1-2 Study of MDV3100 in Patients with Progressive Castration-Resistant Prostate Cancer (CRPC)" (Abstract #5006) will be presented by Howard Scher, M.D., chief of the Genitourinary Oncology Service and the D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center in New York.
|
|
|
Dr. David Hung, President & CEO, will speak at 2.40pm local time.
|
|
Speaker: David Hung, President and Chief Executive Officer
|
|
Speaker: Dr. David Hung, President & CEO
|
Data from the Company's first pivotal trial of Dimebon will be presented by Jeffrey Cummings, M.D. The poster presentation is entitled "Dimebon Stabilizes Neuropsychiatric Symptoms in Alzheimer's Disease: One-year Clinical Trial Results."
|
Speaker: David Hung, M.D., President and Chief Executive Officer
Ritz Carlton Laguna Niguel
Dana Point, CA
|
Speaker: David Hung, M.D, President and Chief Executive Officer
Waldorf-Astoria
New York City, NY
Mr Hung will also participate in an industry panel focused on cognition, entitled 'CNS Companies to Remember', on Wednesday, February 13, at 9:30 a.m. Eastern Time.
|
Speaker: David Hung, M.D., President and Chief Executive Officer
The Grand Hyatt Hotel
New York City, NY
|
|
|
|
 Briefcase
 Download Library
 Email Alerts
 RSS News Feeds
For Investors
investors@medivation.com
For Media
media@medivation.com
Transfer Agent
American Stock Transfer
and Trust Company
59 Maiden Lane
New York, NY 10038
(800) 937-5449
www.amstock.com
|
